0 11

Cited 0 times in

Inactive Rhomboid Protein 2 Mediates Intestinal Inflammation by Releasing Tumor Necrosis Factor-α

Authors
 Jee Hyun Kim  ;  Sung Wook Hwang  ;  Jaemoon Koh  ;  Jaeyoung Chun  ;  Changhyun Lee  ;  Jong Pil Im  ;  Joo Sung Kim 
Citation
 INFLAMMATORY BOWEL DISEASES, Vol.26(2) : 242-253, 2020-01 
Journal Title
 INFLAMMATORY BOWEL DISEASES 
ISSN
 1078-0998 
Issue Date
2020-01
MeSH
Animals ; Carrier Proteins / physiology* ; Colitis / etiology* ; Colitis / pathology ; Cytokines ; Inflammation / etiology* ; Inflammation / metabolism ; Inflammation / pathology ; Intestines / drug effects ; Intestines / immunology* ; Intestines / pathology ; Lipopolysaccharides / pharmacology ; Macrophages / drug effects ; Macrophages / immunology* ; Macrophages / metabolism ; Macrophages / pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Oxidative Stress ; Trinitrobenzenesulfonic Acid / toxicity ; Tumor Necrosis Factor-alpha / metabolism*
Keywords
colitis ; inactive rhomboid protein 2 ; inflammatory bowel disease ; tumor necrosis factor-α
Abstract
Background: Tumor necrosis factor (TNF)-α is a major proinflammatory cytokine that plays a key role in inflammatory bowel disease (IBD). Inactive rhomboid protein 2 (iRhom2) is essential for activating TNF-α-converting enzyme (TACE) in immune cells, which regulates TNF-α release. The aim of the study was to investigate the role of iRhom2 in intestinal inflammation in IBD. Methods: The expression of iRhom2 and TACE in lipopolysaccharide (LPS)-stimulated COLO 205 and RAW 264.7 cells was assessed by reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis. The expression of iRhom2 and TACE in the colonic tissue of IBD patients and 2,4,6-trinitrobenzenesulfonic acid solution (TNBS)-treated mice was determined by RT-PCR and immunohistochemistry. To assess the role of iRhom2 in intestinal inflammation, colitis was induced in wild-type and iRhom2-/- mice by the administration of TNBS enema. Results: In LPS-stimulated COLO 205 and RAW 264.7 cells, the mRNA and protein levels of TACE and iRhom2 were upregulated. The expression of TACE and iRhom2 in the colon of the IBD patients and TNBS-treated mice was significantly enhanced. The inflammatory cells that expressed high levels of iRhom2 in the colon were identified as macrophages. Finally, iRhom2 deficiency ameliorated TNBS-induced colitis by inhibiting TNF-α release. Conclusions: iRhom2 has an important role in intestinal inflammation through TNF-α secretion in immune cells, which suggests that iRhom2 could be a novel therapeutic target for IBD.
Full Text
https://academic.oup.com/ibdjournal/article/26/2/242/5581855
DOI
10.1093/ibd/izz239
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Chun, Jaeyoung(천재영) ORCID logo https://orcid.org/0000-0002-4212-0380
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/180018
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links